Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 475.5 million compared to CNY 459.39 million a year ago. Net income was CNY 88.46 million compared to CNY 80.18 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0846 compared to CNY 0.0767 a year ago. Diluted earnings per share from continuing operations was CNY 0.0846 compared to CNY 0.0767 a year ago.